BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17548494)

  • 1. Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
    Müller FM; Staudigel A; Salvenmoser S; Tredup A; Miltenberger R; Herrmann JV
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3014-6. PubMed ID: 17548494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
    Siikala E; Rautemaa R; Richardson M; Saxen H; Bowyer P; Sanglard D
    J Antimicrob Chemother; 2010 Dec; 65(12):2505-13. PubMed ID: 20876623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Weig M; Müller FM
    Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species.
    Hung CC; Yang YL; Lauderdale TL; McDonald LC; Hsiao CF; Cheng HH; Ho YA; Lo HJ
    J Clin Microbiol; 2005 Apr; 43(4):1600-3. PubMed ID: 15814972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
    Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
    J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
    Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in oropharyngeal colonization and infection by Candida albicans in human immunodeficiency virus-infected patients.
    Diz Dios P; Ocampo A; Otero I; Iglesias I; Martínez C
    J Infect Dis; 2001 Jan; 183(2):355-356. PubMed ID: 11120936
    [No Abstract]   [Full Text] [Related]  

  • 12. Azole susceptibility and resistance in Candida dubliniensis.
    Pinjon E; Moran GP; Coleman DC; Sullivan DJ
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1210-4. PubMed ID: 16246083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study.
    Lin JN; Lin CC; Lai CH; Yang YL; Chen HT; Weng HC; Hsieh LY; Kuo YC; Lauderdale TL; Tseng FC; Lin HH; Lo HJ
    J Microbiol Immunol Infect; 2013 Apr; 46(2):129-35. PubMed ID: 22921200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana.
    Kwamin F; Nartey NO; Codjoe FS; Newman MJ
    J Infect Dev Ctries; 2013 Jan; 7(1):41-5. PubMed ID: 23324819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
    Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis.
    Hamza OJ; Matee MI; Moshi MJ; Simon EN; Mugusi F; Mikx FH; Helderman WH; Rijs AJ; van der Ven AJ; Verweij PE
    BMC Microbiol; 2008 Aug; 8():135. PubMed ID: 18694525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
    Rautemaa R; Richardson M; Pfaller M; Koukila-Kähkölä P; Perheentupa J; Saxén H
    J Antimicrob Chemother; 2007 Oct; 60(4):889-92. PubMed ID: 17704513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
    Walmsley S; King S; McGeer A; Ye Y; Richardson S
    Clin Infect Dis; 2001 Jun; 32(11):1554-61. PubMed ID: 11340526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
    FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.